Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2020  |  Volume : 33  |  Issue : 3  |  Page : 801-805

Serum adiponectin level in osteoporotic postmenopausal women with type 2 diabetes mellitus

1 Internal Medicine Department, Faculty of Medicine, Menoufia, Egypt
2 Tusun Hospital, Abu Qir, Alexandria, Egypt
3 Microbiology and Immunology Department, Faculty of Medicine, Menoufia, Egypt

Correspondence Address:
Mohammed G Habsh
Internal Medicine Department, Faculty of Medicine, Yassin Abdel Ghafar Street from Gamal Abdel Naser Street, Shebin El Kom, Menoufia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mmj.mmj_85_20

Rights and Permissions

Objective The aim was to evaluate the relationships between serum adiponectin level and lumbar bone mineral density (BMD) in osteoporotic postmenopausal women with or without type 2 diabetes mellitus. Background Adiponectin is a novel adipocytokine that could influence bone metabolism. Patients and methods This case–control study was conducted on 55 postmenopausal women selected from diabetic endocrinology inpatient and outpatient clinics. Patients were divided into three groups: osteoporotic group (group A), which included 20 nondiabetic osteoporotic postmenopausal women; diabetic osteoporotic group (group B), which included 20 type 2 diabetic osteoporotic postmenopausal women; and control group (group C), which included 15 nonosteoporotic, nondiabetic women postmenopausal. All patients were subjected to complete history, clinical examination, we measured and recorded the anthropometric measures, fasting blood sugar, hemoglobin A1c, serum calcium, serum phosphorus, parathyroid hormone, thyroid-stimulating hormone, erythrocyte sedimentation rate, C-reactive protein, serum adiponectin levels measured by ELISA, and lumbar spine BMD by dual-energy x-ray absorptiometry scan. Results In osteoporotic group (group A), serum adiponectin had a negative significant correlation with BMD (r=−0.45 and P = 0.04). The diabetic osteoporotic postmenopausal group (group B) showed the lowest concentration of serum adiponectin (μg/ml) compared with group A and the control. Lumbar BMD of group B was significantly higher than that of group A. Conclusion Serum adiponectin is associated with lumber BMD in osteoporotic postmenopausal women, which suggests that serum adiponectin was involved in bone metabolism.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal